Navigation Links
ShanghaiBio Corporation Partners with Ingenuity Systems to Address Challenges in Analysis and Interpretation of Genomics Data
Date:9/5/2012

SHANGHAI, Sept. 5, 2012 /PRNewswire/ -- ShanghaiBio Corporation and Ingenuity® Systems have signed a collaboration agreement enabling ShanghaiBio Corporation to extend its current lab service offering to include Ingenuity solutions for downstream analysis and interpretation of genomics data. ShanghaiBio Corporation will complement their sequencing, genotyping and gene expression lab services by creating a bundled solution with Ingenuity's applications, which combine analytics and biomedical content to help get actionable insights from experiments.

ShanghaiBio Corporation, one of the leading genomics and biomarker service providers with all integrated microarray/next-generation sequencing/PCR/biobanking/pathology capabilities based in China and US, supports global pharmaceutical and biotechnology companies' and academic institutes' drug discovery efforts specifically in the areas of translational medicine and systems biology.  By offering Ingenuity products, ShanghaiBio Corporation supports the complete workflow from study design to bioinformatic analysis, providing its customers with high-quality data and easily interpretable results.

Jason Jin, CEO of ShanghaiBio Corporation, stated, "China is rapidly expanding its investment in the innovative life sciences, drug R&D, and molecular diagnostics sectors. Many organizations including pharmaceutical companies, biotech firms and universities have growing programs for translational medicine research and are faced with analyzing and understanding complex data. With Ingenuity's solutions, we are helping our customers rapidly obtain a detailed assessment of their data so they can move to the next phase of their research."

High throughput experiments generate a significant amount of data, and obtaining insights from that data can be a time-consuming, laborious process. Ingenuity's suite of products, based on the Ingenuity Knowledge Base repository of biological interactions and functional annotations created from the peer-reviewed literature, help researchers interpret the biological meaning of their data.

Dr. Hong Wang, a ShanghaiBio's collaborator and Assistant Professor from Rutgers University, explained, "The Ingenuity iReport analysis tool is essential in helping us understand the biological implications for our gene expression research projects. It is easy to use, and we can get the result within a few hours after we submit the raw data."

About Ingenuity® Systems

Ingenuity Systems is a leading provider of information solutions and custom services for life science researchers, computational biologists and bioinformaticists, and life science industry suppliers. For more information visit: www.ingenuity.com

About ShanghaiBio Corporation

ShanghaiBio Corporation is a leading biotech with lab operations in Shanghai and New Jersey. ShanghaiBio performs total genomics solution services for translational medicine focusing on biobanking, Microarray, Next Generation Sequencing (NGS), and biomarker assay development and companion diagnostics for personalized medicine. For more information, please visit www.ShanghaiBio.com or contact us at info@ShanghaiBio.com.


'/>"/>
SOURCE ShanghaiBio Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Medbox, Inc. Announces Top-Tier Rating by Dun & Bradstreet Credibility Corporation
2. MU celebrates $5 million partnership for advancing biomedical discoveries
3. BGI partners with the University of Birmingham
4. Sandia seeks commercial partners for revolutionary SpinDx medical diagnostic tool
5. F1000 Research partners with figshare to provide smart ways of accessing data
6. Royal Astronomical Society and Oxford University Press partnership announced
7. Grants add to Northwestern-Qatar partnership
8. New museum-university partnership ushers in new era of environmental science education
9. Ducks Unlimited Canada and Canadian Light Source partnership to shed light on wetlands
10. Science, Innovation, and Partnerships for Sustainability -- Symposium May 16-18
11. M2SYS Technology Partners with Hitachi to Offer Innovative Biometric Finger Vein Scanner to US Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/16/2016)... SANTA CLARA, Calif. , Nov. 16, 2016 /PRNewswire/ ... company enhancing user experience and security for consumer ... provider for the financial and retail industry, today ... more secure and convenient way to authenticate users ... now uses Sensory,s TrulySecure™ software which ...
(Date:11/14/2016)... Inc. ("xG" or the "Company") (Nasdaq: XGTI, XGTIW), a ... challenging operating environments, announced its results for the third ... conference call to discuss these results on November 15, ... Key Recent Accomplishments The ... Vislink Communication Systems. The purchase is expected to close ...
(Date:6/22/2016)... -- The American College of Medical Genetics and Genomics was once ... one of the fastest-growing trade shows during the Fastest 50 ... Las Vegas . Winners ... each of the following categories: net square feet of paid ... The 2015 ACMG Annual Meeting was ranked 23 out of ...
Breaking Biology News(10 mins):
(Date:12/7/2016)... -- Muse bio, a privately-held company leading the development of ... Kevin Ness has been appointed Chief Executive Officer ... Kevin succeeds Muse bio,s founding CEO Ryan ... as well as remains Slade Professor, Chemical and Biological ... the RAS Energy Institute at the University of Colorado, ...
(Date:12/7/2016)... ... December 07, 2016 , ... JULABO ... online shopping cart. The new website has been designed to provide the best ... allow customers to access detailed product information, read educational industry content as well ...
(Date:12/6/2016)... PA (PRWEB) , ... December ... ... part of the Almac Group, the world’s largest privately-held contract pharmaceutical development ... with inVentiv Health, a leading biopharma outsourcing company combining a leading CRO ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... company, today announced it has acquired the assets of Theorem Clinical Research ... and focuses on clinical trial drug packaging, labeling, storage, reconciliation, and distribution ...
Breaking Biology Technology: